Your browser doesn't support javascript.
loading
Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo, Yingqi; Wu, Wenhao; Zha, Dailong; Zhou, Wenmin; Wang, Chengxu; Huang, Jianan; Chen, Shaobin; Yu, Lihong; Li, Yuanzhi; Huang, Qinghui; Zhang, Jianye; Zhang, Chao.
Afiliación
  • Luo Y; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China; The State Key Laboratory of Respiratory Disease & NMPA Key Laboratory for Clinical Research and Evaluation
  • Wu W; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China; The State Key Laboratory of Respiratory Disease & NMPA Key Laboratory for Clinical Research and Evaluation
  • Zha D; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Zhou W; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Wang C; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Huang J; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Chen S; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Yu L; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China; The State Key Laboratory of Respiratory Disease & NMPA Key Laboratory for Clinical Research and Evaluation
  • Li Y; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China.
  • Huang Q; The First Affiliated Hospital, Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangdong 510180, China. Electronic address: hyshqh889@vip.163.com.
  • Zhang J; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China; The State Key Laboratory of Respiratory Disease & NMPA Key Laboratory for Clinical Research and Evaluation
  • Zhang C; The Fifth Affiliated Hospital & School of Pharmaceutical Sciences, Key Laboratory of Molecular Target & Clinical Pharmacology, Guangzhou Medical University, Guangzhou 511436, China; The State Key Laboratory of Respiratory Disease & NMPA Key Laboratory for Clinical Research and Evaluation
Bioorg Med Chem Lett ; 47: 128230, 2021 09 01.
Article en En | MEDLINE | ID: mdl-34186178
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Chalcona / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Chalcona / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido